A Dual-Type L2 11-88 Peptide from HPV Types 16/18 Formulated in Montanide ISA 720 Induced Strong and Balanced Th1/Th2 Immune Responses, Associated with High Titers of Broad Spectrum Cross-Reactive Antibodies in Vaccinated Mice

@inproceedings{Khiavi2018ADL,
  title={A Dual-Type L2 11-88 Peptide from HPV Types 16/18 Formulated in Montanide ISA 720 Induced Strong and Balanced Th1/Th2 Immune Responses, Associated with High Titers of Broad Spectrum Cross-Reactive Antibodies in Vaccinated Mice},
  author={Farhad Motavalli Khiavi and Arash Arashkia and Majid Golkar and Maryam Nasimi and Farzin Roohvand and Kayhan Azadmanesh},
  booktitle={Journal of immunology research},
  year={2018}
}
E. coli-derived concatenated, multitype L2-conserved epitopes of human papillomavirus (HPV) L2 protein might represent a less expensive and pan-type vaccine alternative (compared to type-specific HPV L1 virus-like particles), if stable protein expression and strong immunogenicity features could be met. Herein, three dual-type- (DT-) HPV L2 fusion peptides comprising the three head-to-tail tandem repeats (multimers) of either HPV 16 epitope "17-36" or "69-81" or one copy (monomer) of 11-88 fused… CONTINUE READING

Similar Papers

References

Publications referenced by this paper.
SHOWING 1-10 OF 75 REFERENCES

Epidemiology of HPV-Positive Tumors in Europe and in the World.

  • Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer
  • 2017